Cargando…
Decline and loss of anti–SARS-CoV-2 antibodies in kidney transplant recipients in the 6 months following SARS-CoV-2 infection
Autores principales: | Chavarot, Nathalie, Leruez-Ville, Marianne, Scemla, Anne, Burger, Carole, Amrouche, Lucile, Rouzaud, Claire, Lebreton, Xavier, Martinez, Frank, Sberro-Soussan, Rebecca, Legendre, Christophe, Zuber, Julien, Anglicheau, Dany |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society of Nephrology. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830266/ https://www.ncbi.nlm.nih.gov/pubmed/33509358 http://dx.doi.org/10.1016/j.kint.2020.12.001 |
Ejemplares similares
-
Ig-responsive relapsing inflammatory syndrome following COVID-19 in a kidney transplant recipient
por: Chavarot, Nathalie, et al.
Publicado: (2021) -
Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept
por: Chavarot, Nathalie, et al.
Publicado: (2021) -
Early treatment with sotrovimab monoclonal antibody in kidney transplant recipients with Omicron infection
por: Chavarot, Nathalie, et al.
Publicado: (2022) -
Conversion From Intravenous In-Hospital Belatacept Injection to Subcutaneous Abatacept Injection in Kidney Transplant Recipients During the First COVID-19 Stay-at-Home Order in France
por: Bertrand, Dominique, et al.
Publicado: (2023) -
Immune Responses in SARS-CoV-2, SARS-CoV, and MERS-CoV Infections: A Comparative Review
por: Irani, Soussan
Publicado: (2022)